脑膜瘤的T细胞抗原图谱:免疫治疗的新选择
Gioele Medici1,2, Lena K Freudenmann3,4,5, Julia Velz6,7
1Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland. gioele.medici@usz.ch.
Acta neuropathologica
|June 27, 2023
概括
研究人员为脑膜瘤 (一种常见的大脑瘤) 创建了一个T细胞抗原图谱,以找到新的免疫治疗点. 该图谱识别了瘤特有的抗原,为不良临床过程的患者提供了潜在的新治疗选择.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 脑膜瘤是最常见的原发性内瘤,通常需要除了手术和放射治疗之外的额外治疗.
- 外动脉的长期分支透脑膜瘤,这表明免疫疗法可能是一个可行的治疗方法.
- 脑膜瘤所呈现的特定瘤抗原目前尚不清楚,这阻碍了向免疫疗法.
研究的目的:
- 通过对其自然呈现的免疫组进行剖析,创建一个T细胞抗原图谱,用于脑膜瘤.
- 为了识别HLA类I和II的T细胞抗原,仅限于脑膜瘤.
- 通过体外检测验证排名最高的候选抗原的免疫性.
主要方法:
- 使用液体染色学-并联质谱法 (LC-MS/MS) 进行深入的免疫型样本分析.
- 对正常组织广泛的免疫皮组数据集进行比较分析,以识别独特的抗原.
- 在体外T细胞原始化试验以评估选择的抗原的免疫性.
主要成果:
- 为脑膜瘤生成了一个全面的T细胞抗原图谱.
- 首次确定了HLA类I和II的脑膜瘤专属抗原.
- 顶级候选抗原的免疫性通过功能测试得到证实.
结论:
- 这项研究提供了一个有价值的T细胞抗原图谱,用于脑膜瘤,这将是公众可访问的.
- 已经确定了脑膜瘤免疫治疗的新,可操作的标.
- 这些发现需要进一步研究为脑膜瘤患者的潜在免疫疗法选择.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.0K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
